We are live on
!
Find out more
MC
Metropolis Capital Portfolio holdings
AUM
$3.45B
1-Year Est. Return
1.26%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+1.26%
3 Year Est. Return
+54.39%
5 Year Est. Return
+55.34%
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$63.4M
(+15%)
Cap. Flow
+$59.5M
Cap. Flow
% of AUM
11.9%
Top 10 Holdings %
Top 10 Hldgs %
99.12%
Holding
11
New
–
Increased
8
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$17.2M |
| 2 |
HCA Healthcare
HCA
|
+$16.2M |
| 3 |
State Street
STT
|
+$13.9M |
| 4 |
Ryanair
RYAAY
|
+$13.3M |
| 5 |
Booking.com
BKNG
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$24.5M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$5.7M |
| 3 |
Oracle
ORCL
|
+$454K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.49% |
| 2 | Industrials | 17.4% |
| 3 | Healthcare | 17.11% |
| 4 | Communication Services | 13.77% |
| 5 | Consumer Discretionary | 12.95% |
Similar funds
RBA
PWP
PCM
LNC
JGC
DAM
OTPPB
CIA
Metropolis Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Metropolis Capital held 11 positions worth $500M, up 15% from $436M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Metropolis Capital deployed $59.5M of net new capital in Q3 2019, adding to 8 existing holdings.
By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Allergan plc, an estimated $24.5M trimmed.
- Metropolis Capital added most to Berkshire Hathaway Class B in Q3 2019, an estimated $17.2M increase.
- Metropolis Capital's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $24.5M.
- Metropolis Capital's ten largest holdings make up 99% of its $500M portfolio in Q3 2019.
- Metropolis Capital opened 0 new positions and closed 0 in Q3 2019.
- Metropolis Capital's portfolio value rose 15% quarter-over-quarter to $500M.
Based on Metropolis Capital's 13F filing for Q3 2019, filed 4 Oct 2019.